Related by context. Frequent words. (Click for all words.) 65 BioMarin Genzyme LLC 64 FQ = fiscal 64 Inc Morning Commentary 64 Meets Estimates 63 SangStat 63 Including discontinued operations 63 THALOMID 63 Preliminary Second Quarter 62 BioGlue R 62 Nasdaq VRTX 62 Inc. FY# Q3 62 Inc. Nasdaq TRMS 62 3Q FY# 62 Reaffirms Guidance 62 R sorafenib tablets 62 Files Shelf Registration Statement 62 CFO Exercises Options 62 BioDelivery Sciences 61 Excluding nonrecurring items 61 Nasdaq BIIB 61 Inc. Nasdaq IMGN 61 Analysts Upgrades Downgrades 61 4Q Profit Jumps 61 Sunesis Pharmaceuticals 61 Q1 Loss Narrows 61 Q3 Loss Narrows 61 debt extinguishments 61 Record Second Quarter 61 Preliminary Third Quarter 61 NASDAQ DYAX 61 Director Exercises Options 60 Earnings Scorecard 60 Inc. NASDAQ QLTI 60 Updates Guidance 60 Updates Fourth Quarter 60 4Q Loss Widens 60 Nasdaq AMGN 60 Q2 Loss Narrows 60 obj obj = 60 Hold Third Quarter 60 Cuts FY# 60 No. #R 60 Inc. Nasdaq MEDX 60 Accelerated Share Repurchase 60 Record Fourth Quarter 60 See BioWorld Today 60 Guides Above 60 Q1 Loss Widens 60 Q3 Profit Surges 60 Hold Fourth Quarter 60 Backs FY# EPS 59 Eligard ® 59 NASDAQ CRXL 59 Q2 FY# [001] 59 pershare 59 Approaching Resistance 59 Inc. NASDAQ SNTS 59 Inc. NASDAQ AGEN 59 Corp. Nasdaq GENZ 59 Guides Q1 59 FY# Q2 59 Q2 Loss Widens 59 www.vivus.com 59 NASDAQ OSIR 59 USD #.#bln [001] 59 Lowers Guidance 59 ZEGERID Capsules 59 Takeda Kyowa Hakko Kirin 59 Corp. FY# Q3 59 Initiates Phase II 59 Tops Estimate 58 visit www.PAREXEL.com 58 4Q FY# 58 Guides Q4 58 unconsolidated joint 58 Inc. NASDAQ CEPH 58 FY# Guidance 58 Therapeutic Competitors 58 FREE Whitepaper 58 Guides Q3 58 Ethyol 58 Bearish Pressure Building 58 Puts Purchased 58 Lifts FY# EPS 58 Crucell NV Euronext 58 Nasdaq AMLN 58 Eyetech Pharmaceuticals 58 Net Loss Narrows 58 Posts 4Q Loss 58 GVAX R 58 Guides Q2 58 Record Third Quarter 58 Raises FY# 58 Revenues Decline 58 Coming Biotech Boom 58 Posts 3Q 58 Guides Below 58 Chugai Pharmaceutical Japan 58 By Thomas Gryta 58 PLAVIX R 58 ICOS Corporation